Javitt Daniel C.

Insider profile

Javitt Daniel C.'s trades of NRX Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2022-12-01 2022-11-30 PlS Planned sale
93,045 -2.1%
466.97
US$2,712,507
93,045 -2.1% 466.97 US$2,712,507
2022-12-01 2022-11-29 PlS Planned sale
43,781 -44.5%
438.67
US$3,029,749
43,781 -44.5% 438.67 US$3,029,749
2022-11-18 2022-11-17 PlS Planned sale
16,639 +44.4%
351.92
US$3,073,628
16,639 +44.4% 351.92 US$3,073,628
2022-11-18 2022-11-16 PlS Planned sale
133,719 -1.4%
1.02
US$136,393
133,719 -1.4% 1.02 US$136,393
2022-11-15 2022-11-11 PlS Planned sale
49,200 -0.5%
1.01
US$49,510
49,200 -0.5% 1.01 US$49,510
2022-08-02 2022-07-29 S Sale
784,063 -7.4%
1.01
US$791,433
784,063 -7.4% 1.01 US$791,433
2022-06-07 2022-06-07 S Sale
86,459 -0.7%
0.65
US$55,861
86,459 -0.7% 0.65 US$55,861
2022-06-07 2022-06-06 S Sale
115,657 -0.9%
0.67
US$76,947
115,657 -0.9% 0.67 US$76,947
2022-06-07 2022-06-03 S Sale
243,596 -1.9%
0.70
US$171,102
243,596 -1.9% 0.70 US$171,102